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The antiphagocytic polysaccharide capsule of the
human fungal pathogen Cryptococcus neoformans
is a major virulence attribute. However, previous
studies of the pleiotropic virulence determinant
Gat201, a GATA family transcription factor, sug-
gested that capsule-independent antiphagocytic
mechanisms exist. We have determined that Gat201
controls the mRNA levels of 1100 genes (16% of
the genome) and binds the upstream regions of
130 genes. Seven Gat201-bound genes encode
for putative and known transcription factors—
including two previously implicated in virulence—
suggesting an extensive regulatory network. System-
atic analysis pinpointed two critical Gat201-bound
genes, GAT204 (a transcription factor) and BLP1,
which account for much of the capsule-independent
antiphagocytic function of Gat201. A strong correla-
tion was observed between the quantitative effects
of single and double mutants on phagocytosis
in vitro and on host colonization in vivo. This genetic
dissection provides evidence that capsule-indepen-
dent antiphagocytic mechanisms are pivotal for
successful mammalian infection by C. neoformans.
INTRODUCTION
The fungus Cryptococcus neoformans is a leading cause of
morbidity and mortality in AIDS patients, resulting in one million
cases and 600,000 deaths annually worldwide (Park et al., 2009).
Although cryptococcosis is typically associated with immunode-
ficient patients, a recent outbreak caused by the sister species
Cryptococcus gattii in the Pacific Northwest has resulted in the
deaths of numerous immunocompetent individuals (Datta
et al., 2009). It is thus critical to understand the interactions of
theCryptococcus species complex with themammalian immune
system.
C. neoformans is thought to be acquired through the inhalation
of spores or yeast (Botts and Hull, 2010), and alveolar macro-
phages are considered the first line of defense against crypto-
coccal infection. Experimental evidence supports this, particu-Cell Holarly early in infection (Monga, 1981; Osterholzer et al., 2009).
C. neoformans can also survive and proliferate within the phag-
olysosome, as well as exit macrophages by lytic and nonlytic
pathways, all of which might be important for pathogenesis
(Voelz and May, 2010). Macrophage activation has been shown
to be important for T cell proliferation, the development of the
T cell response, and chemokine-mediated recruitment of neutro-
phils and monocytes into the tissue (Monari et al., 2006a).
C. neoformans is rarely taken up by macrophages in the
absence of opsonizing agents such as complement or anti-
bodies, even after 24 hr of coincubation (Levitz andDiBenedetto,
1989; Liu et al., 2008). This is in striking contrast to other yeasts:
unopsonized Saccharomyces cerevisiae orCandida albicans are
phagocytosed after less than 1 hr of coincubation (Lohse and
Johnson, 2008; Tejle et al., 2002). Opsonizing agents are likely
to be present in lower levels early in infection. Within the lungs,
complement is not present at constitutively high levels, but is
synthesized in response to infection by many different cell types
within the lungs and other tissues in a process that is estimated to
take up to 1week (Blackstock andMurphy, 1997; Rothman et al.,
1989). Antibody generation is thought to take 2 to 5 weeks
for peak production (Nussbaum et al., 1999). Therefore, cell-
mediated killing bymacrophages during the initial infection, prior
to complement and antibody generation, is likely to be important
for limiting proliferation of the invading pathogen. Studies have
shown that AIDS patients generate less anti-C. neoformans
antibody than healthy patients, and the severe prognosis for
cryptococcosis in AIDS patients may be linked to this defect
(Subramaniam et al., 2009). Antibodies generated by infected
AIDS patients may be less protective against C. neoformans
infection or produced at titers too low for effective opsonization,
or production couldbecritically delayedearly in infection (Dromer
et al., 1988, 1995). It is thus possible that yeast evasion of phago-
cytosis by macrophages plays an important role in the develop-
ment of cryptococcosis in immunocompromised individuals.
The characteristic polysaccharide capsule ofC. neoformans is
considered one of its chief virulence traits. Its primary compo-
nents are glucuronoxylomannan (GXM) and galactoxylomannan
(GalXM), two high-molecular-mass polymers that have immuno-
modulatory properties, including suppression of both adaptive
and innate immune mechanisms (Monari et al., 2006a, 2006b)
The production of capsule byC. neoformans has been previously
associated with inhibition of phagocytosis, although this correla-
tion has been reported predominantly in the context ofC. neofor-
mans cells opsonized with serum (Del Poeta, 2004). It remainsst & Microbe 9, 243–251, March 17, 2011 ª2011 Elsevier Inc. 243
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contribute to inhibition of unopsonized phagocytosis, which is
presumably relevant to the control of disease early in the infec-
tion process. While the capsule is clearly an important virulence
trait, clinical studies have suggested for decades the existence
of important capsule-independent mechanisms: cryptococcosis
cases produced by capsule-deficient strains exhibit a similar
clinical course as infections produced by capsule-proficient
strains (Torres et al., 2005).
Previously, our group described the first large-scale system-
atic genetic screen for virulence determinants of C. neoformans
(Liu et al., 2008). We constructed and analyzed 1200 gene
knockout strains in the background of the H99 clinical isolate
of C. neoformans var grubii (serotype A). A signature-tagged
mutagenesis screen led to the identification of numerous factors
required for the expression of known virulence factors, as well as
dozens of genes that contributed to virulence independently of
known mechanisms. Among the mutants that produced the
strongest defect in infectivity but did not affect proliferation
rate at body temperature was a deletion in the GAT201 gene
(Liu et al., 2008). GAT201 encodes a member of the GATA family
of zinc-finger transcriptional regulators that is conserved from
yeast to man (Teakle and Gilmartin, 1998). A GAT201 knockout
mutant shows reduced capsule size and dramatic attenuation
in virulence in a mouse inhalation model of infection. Signifi-
cantly, we found that gat201D mutants are robustly taken up
by macrophages in unopsonized conditions. In contrast, less
than 1% of macrophages are associated with yeast when in-
fected with wild-type C. neoformans for the same period. The
defect in phagocytosis evasion by gat201D cells cannot be ex-
plained by the capsule size defect exhibited by gat201D cells:
cap10D, cap60D, and cap64D cells, which are devoid of capsule,
display amuchmoremodest increase in association withmacro-
phages than a gat201D mutant. More importantly, when CAP
genes are knocked out in combination with GAT201, the result-
ing capDgat201D strains still show dramatically increased
percentages of macrophages with associated yeast cells over
that displayed by the single capmutants. These data suggested
that Gat201 inhibits phagocytosis via both capsule-dependent
and capsule-independent mechanisms (Liu et al., 2008).
However, the relative contribution of these two functions to the
virulence function of Gat201 remained to be addressed.
Given that Gat201 is predicted to be a transcriptional regu-
lator, understanding its role in virulence requires identification
and characterization of its direct targets. Chromatin immunopre-
cipitation-microarray hybridization (ChIP-chip) and chromatin
immunoprecipitation sequencing (ChIP-seq) are ideal methods
for identifying direct targets of transcription factors, but the
application of these methods to C. neoformans (whose polysac-
charide capsule thickness can exceed the diameter of the cell) is
nontrivial. In this study, we report the successful development
of ChIP-chip methods for capsule-bearing C. neoformans, the
identification of the direct targets of Gat201, and detailed
analysis of these targets by systematic gene disruption and
phenotypic characterization. We demonstrate that two targets,
GAT204 and BLP1, together explain a bulk of the capsule-inde-
pendent phagocytosis evasion (‘‘antiphagocytosis’’) activity of
Gat201 and that they are critical for C. neoformans’s ability to
colonize the mammalian lung early in the infection process.244 Cell Host & Microbe 9, 243–251, March 17, 2011 ª2011 ElsevierRESULTS
Gat201 Controls the Expression of 1100 Genes in
Response to Environmental Cues
Our previous work (Liu et al., 2008) indicated that Gat201 is a key
virulence regulator, possibly through its inhibition of phagocy-
tosis by macrophages. As Gat201 is a GATA family transcription
factor, we usedmicroarray-based expression profiling to identify
genes that are transcriptionally regulated by Gat201 (Figure 1A).
When we compared the transcript profiles of wild-type cells to
gat201D cells grown in standard yeast culture conditions
(30C, YPAD medium, atmospheric CO2), we observed few
changes in messenger RNA (mRNA) accumulation as deter-
mined with statistical analysis of microarrays (SAM) analysis
(Tusher et al., 2001). In comparison, when the strains were
cultured in tissue culture conditions (37C, Dulbecco’s modified
Eagle’s medium [DMEM], 5% CO2), the same conditions used
for culturing macrophages, we saw a dramatic Gat201-depen-
dent transcriptional program (Figure 1B). Over 1100 genes
(16%of the genome) showed aR2-fold difference in transcript
levels and were identified by SAM analysis as differentially up- or
downregulated in a Gat201-dependent manner. We performed
time course experiments utilizing RT-qPCR to examine gene
expression of two representative genes from the upregulated
set (MEU1 and CNJ1810) after transfer of cells from yeast to
tissue culture conditions. Through the time course, we observed
steady increases in transcript levels, with maximal expression
occurring between 8 and 24 hr after transfer (Figure 1C). Interest-
ingly, GAT201 RNA levels also increased dramatically under
these conditions, suggesting a positive feedback loop.
Gat201 Binds the Promoters of 126 Genes and Controls
mRNA Levels of 62 of These Genes
To identify genes directly bound byGat201, we used aChIP-chip
approach (Nobile et al., 2009). We tagged the endogenous
GAT201 gene with a C-terminal calmodulin-binding peptide-2X
FLAG (CBP-2XFLAG) epitope. For these studies, we developed
a ChIP protocol for encapsulated cells (see the Supplemental
Experimental Procedures). Immunoprecipitated DNA (IP) and
reference DNA (WCE) from a Gat201-CBP-2XFLAG-expressing
and an untagged parent strain were amplified and hybridized
against a custom microarray spanning the entire genome of
the strain H99. We identified 126 genes that show enrichment
of Gat201-CBP-2XFLAG in their promoter regions when
compared to the reference DNA and the untagged control strain
(Figure 1D). As predicted from our time course analysis, Gat201-
CBP-2XFLAG binds in the promoter ofGAT201 itself (Figure 1E).
Having identified genes with Gat201-CBP-2XFLAG bound in
their promoters, we next sought to determine whether their tran-
scriptionwasGat201-dependent (Figure S1 available online).We
used RT-qPCR to quantify the mRNA levels for 126 genes with
the strongest enrichment for Gat201-CBP-2XFLAG in their
promoters, comparing wild-type and gat201D cells grown in
yeast culture and tissue culture conditions. Transcript levels
were normalized to the levels found in wild-type cells grown in
yeast culture conditions. We identified a set of 62 Gat201-bound
genes that demonstrated Gat201-dependent transcription
induction in tissue culture conditions (Table 1). The promoter
regions of these genes are enriched for a 7 nt motif whenInc.
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Figure 1. Identification of Gat201 Transcrip-
tional Program and Direct Gat201 Targets
(A) Schematic of growth conditions used for tran-
scriptional microarrays of yeast cells grown in
tissue culture conditions (DMEM, 37C, 5% CO2)
or yeast culture conditions (YPAD, 30C, atmo-
spheric CO2).
(B) Transcript profiling with customwhole-genome
DNA microarrays was performed comparing
gat201D versus wild-type cells grown in tissue
culture and in yeast culture conditions. Genes
shown are those with both a minimum of a 2-fold
change and a statistically significant difference
(with SAM analysis) between expression profiles
in tissue culture and yeast media conditions.
Values are plotted as the average ratio of transcript
level in gat201D cells versus wild-type cells (log2)
from four arrays per growth condition.
(C) RT-qPCR analysis of the indicated transcripts
after transfer from yeast culture conditions into
tissue culture conditions. Samples were harvested
at the indicated time points after transfer for RNA
isolation and complementary DNA synthesis. Error
bars at the 24 hr time point are the standard devi-
ation of two samples.
(D) Global summary of ChIP-chip results. Genes
enriched for Gat201-CBP-2XFLAG bound in their
promoter regions were identified by comparing
signals from replicate experiments performed
with untagged and tagged strains. Genes dis-
played are those with the largest difference
between tagged and untagged genotypes in
median value of the top five probe values among
those within 1 kb of the predicted translational
start site. Depicted are the ratios (log2) of immuno-
precipitated DNA (IP) to whole-cell extract (WCE)
for each probe.
(E) Example of ChIP-chip data. Ratios (log2) of IP
DNA to WCE were plotted for each probe of the
two tiling arrays at the chromosomal coordinates
indicated. Asterisks indicate locations of motif in
the chromosomal sequence shown.
(F) Gat201 directly binds the regulatory regions of
set of known and putative transcription factors.
See also Figure S2.
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mans genome (Figure S2A). Strikingly, Gat201 activates the
transcription of genes encoding seven known and putative tran-
scription factors: CNBJ1500-A, GAT204, ECM2201, CIR1, LIV3,
YLR236C02, and MET32. These results suggest that Gat201
controls its remarkably large transcriptional regulon in part by
activating the transcription of genes coding for downstream
regulators (Figure 1F).
Identification of Key Gat201-Bound Genes
Weconsidered the 62 direct downstream targets of Gat201 to be
likely effectors of Gat201-mediated phagocytosis inhibition. We
thus targeted each of these genes for deletion by homologous
recombination (Figure S1A). We successfully knocked out 46
of 62 genes and then tested each of the mutant strains for
phagocytosis defects by coincubation with RAW264.7 macro-
phages. Two genes emerged as having a role in phagocytosis
inhibition: CNAG_06346 and CNAG_06762. CNAG_06346Cell Hoencodes a protein with a highly conserved Barwin-like domain
that we named Barwin-like protein 1 (Blp1). CNAG_06762
encodes for the GATA family transcription factor that we previ-
ously annotated as Gat204 (Chow et al., 2007). BLP1 and
GAT204 show enhanced binding of Gat201-CBP-2XFLAG in
their promoter regions (Figure S2B), and their expression is
Gat201-dependent in tissue culture conditions (Figure 2A).
As Gat204 is itself a transcription factor, we examined BLP1
transcription in gat204D cells. BLP1 expression is increased in
gat204D cells in tissue culture conditions (Figure 2B), suggesting
that Gat204 may negatively regulate BLP1 transcription or that
BLP1 transcription is upregulated as a compensatory mecha-
nism when Gat204 is lost.
Gat201-Bound Genes Mediate Its Antiphagocytic
Function
After 24 hr coincubation with blp1D cells, approximately 2.5% of
RAW264.7 macrophages were associated with yeast, a modestst & Microbe 9, 243–251, March 17, 2011 ª2011 Elsevier Inc. 245
Table 1. Gat201 Target Genes
CNAG Number CDS Number WT/gat201D DMEM Induction Name Annotation
CNAG_06517 CDS_4922 144.51 117.50 YOR296W02 C2 domain-containing protein
CNAG_04736 CDS_5892 103.76 153.95 CNJ1800 unknown
CNAG_06186 CDS_1099 37.53 103.95 CNM1740 sugar transport
CNAG_01553 CDS_3244 35.87 36.20 CNC0890 CHORD-containing protein
CNAG_05867 CDS_3724 32.25 239.48 CNF3650 fucose permease
CNAG_01601 CDS_2811 31.95 195.53 ATG15 potential vacuolar triglyceride lipase
CNAG_06389 CDS_7034 31.10 20.86 – unknown
CNAG_05147 CDS_5668 23.64 51.11 CNI2090 unknown
CNAG_04735 CDS_5889 23.00 69.96 CNJ1810 metalloprotease
CNAG_00165 CDS_4036 18.59 39.71 MEU1 phosphorylase
CNAG_04756 CDS_5770 15.69 72.05 CNJ1610 ribonuclease H-related protein
CNAG_00331 CDS_4152 8.49 22.77 YMR210W01 alpha/beta hydrolase fold
CNAG_02553 CDS_1762 8.31 17.90 SPS1904 putative oxidoreductase
CNAG_05821 ND 8.20 20.59 – unknown
CNAG_03848 CDS_6469 8.07 22.97 CNB2310-B putative glutaredoxin
CNAG_05312 CDS_5280 7.93 3.45 CNI3590 macrophage-activating glycoprotein
CNAG_00456 ND 6.93 24.06 – unknown
CNAG_00374 CDS_6603 6.27 10.73 – unknown
CNAG_01777 CDS_2931 6.19 1.47 YNL274C03 glyoxylate reductase
CNAG_00919 CDS_669 5.67 3.05 KEX101 carboxypeptidase S3
CNAG_06762 CDS_5944 5.57 36.16 GAT204 GATA family transcription factor
CNAG_01552 CDS_3426 5.38 44.66 BET1 T-SNARE membrane protein
CNAG_06346 ND 5.04 5.14 BLP1 Barwin-like domain
CNAG_05640 CDS_5612 5.02 7.19 SMF1 NRAMP manganese transporter
CNAG_06493 CDS_4944 4.81 14.99 CNN2220 unknown
CNAG_02189 CDS_1614 4.68 7.46 YJL216C putative alpha amylase
CNAG_03012 CDS_2777 4.52 2.07 QSP1 quorum-sensing peptide
CNAG_02777 CDS_3007 4.49 158.67 PHO840 putative phosphate transporter
CNAG_05664 CDS_5254 2.17 1.22 BAT1 branched amino acid transaminase
CNAG_03136 CDS_2688 4.29 20.43 CNG0410 putative fatty acid synthase
CNAG_04768 CDS_5907 4.14 6.35 CNBJ1500-A Gal4-like DNA binding domain
CNAG_06098 CDS_1286 4.09 5.40 CNM0910 glucosamine-6-phosphate
CNAG_03122 ND 3.82 772.37 – unknown
CNAG_06200 CDS_1088 3.70 3.92 CNM1860 PAS domain-containing protein
CNAG_06242 CDS_1107 3.56 8.20 CFT1 high-affinity iron permease
CNAG_06108 ND 3.40 2.83 – unknown
CNAG_01778 CDS_3364 3.30 6.15 CNC4450 mitochondrial carrier protein-like
CNAG_04737 CDS_5893 3.25 1.50 CNJ1790 potential methyltransferase
CNAG_04517 ND 3.21 3.64 – unknown
CNAG_00883 CDS_781 3.00 11.16 ECM2201 Gal4-like DNA binding
CNAG_05229 CDS_5329 2.86 19.11 CNI2770 stomatin-like protein
CNAG_00884 CDS_775 2.74 5.74 SEC10 unknown
CNAG_03413 CDS_2415 2.73 9.52 CNG3070 alginate lyase
CNAG_04312 CDS_112 2.43 2.88 PMI4001 mannose-6-phosphate isomerase
CNAG_05835 CDS_3521 2.35 3.21 LIV3 Wor1-like transcription factor
CNAG_03915 CDS_6280 2.32 9.78 CNB1700 unknown
CNAG_04140 CDS_43 2.20 4.99 CNH2650 unknown
CNAG_02856 CDS_3358 2.20 2.05 TRK1 putative potassium transporter
CNAG_03412 CDS_2417 2.16 3.97 CTS202 chitinase
CNAG_02219 CDS_1876 2.08 1.71 YLR247C02 zinc finger
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Table 1. Continued
CNAG Number CDS Number WT/gat201D DMEM Induction Name Annotation
CNAG_03847 CDS_6346 2.08 7.85 CNB2320 unknown
CNAG_01681 CDS_2877 2.07 10.13 FCY2201 putative purine-cytosine permease
CNAG_06763 CDS_5942 2.05 6.61 DIA4 putative seryl-tRNA synthetase
CNAG_04864 CDS_5991 2.01 3.22 CIR1 GATA-type transcription factor
CNAG_04436 CDS_146 1.99 12.71 CNH1150 unknown
CNAG_04435 ND 1.97 6.83 – ferric reductase
CNAG_00184 CDS_4067 1.84 1.87 PCF11 Pre-mRNA cleavage complex II
CNAG_00068 CDS_4631 1.81 7.46 MET32 Zn C2H2-domain containing protein
CNAG_06187 ND 2.54 3.39 STR1 streptomycin biosynthesis protein
CNAG_01040 CDS_703 24.63 10.64 KEX102 carboxypeptidase S3
CNAG_05159 ND 18.83 6.09 – unknown
CNAG_00546 CDS_4340 2.95 5.68 CHS301 chitin synthase
Genes with Gat201-CBP-2XFLAG bound in their promoter with Gat201-dependent induction in tissue culture conditions. CNAG numbers are gene
identifiers from the Broad Institute’s annotation of H99. CDS numbers are gene identifiers from our annotation. ‘‘WT/gat201D’’ refers to the ratio of
transcript level for a given gene in wild-type cells over that in gat201D cells in tissue culture conditions. ‘‘DMEM induction’’ is the amount of transcript
for a given gene in wild-type cells grown in tissue culture conditions relative to the transcript level in wild-type cells grown in yeast culture conditions.
When previously characterized in the literature, the name for a gene is given. If there is no prior reference to the gene, the name assigned in our anno-
tation is given, if available. Annotations were assigned by BLASTP and SMART analysis. Italics indicate those genes that were not successfully
knocked out.
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macrophages associated with wild-type yeast (Figure 2C). Coin-
cubation with gat204D cells resulted in yeast association in9%
of RAW264.7 cells. Strikingly, two independently-derived
double-knockout strains in GAT204 and BLP1 showed 25%–
30% of RAW264.7 macrophages associated with C. neofor-
mans, indicating a functional synergy in their mechanism of
phagocytosis inhibition, and recapitulating almost 40% of the
original Gat201-dependent phenotype. We also observed this
synergistic increase in phagocytosis in bone marrow-derived
macrophages (BMDMs) (Figure S3A). Finally, we distinguished
between macrophage-internalized and -externally associated
yeast cells using differential staining techniques. We confirmed
that the gat204D and blp1D mutations acted synergistically to
produce increases in actual uptake. We also documented an
increase in external association of gat204D, blp1D, and
gat204Dblp1D strains (Figures S3B and S3C), which suggests
that recognition and adherencemay bewhat is triggering phago-
cytosis in the mutants.
Agrobacterium Transfer DNA Insertion Screen
Independently Identifies GAT201 and GAT204
Our original knockout library only covered a portion of the
C. neoformans genome, so we sought a more global approach
to identify anti-phagocytic factors. We therefore used the
Agrobacterium tumefaciens transfer DNA system (McClelland
et al., 2005) to produce insertional mutants across theC. neofor-
mans genome and then screened this mutant library for anti-
phagocytosic defects (Figure S1B). A library of 30,000
insertions was generated, from which 2 3 108 yeast cells from
overnight YPAD culture were added to plated RAW264.7 macro-
phages. After rounds of selection for phagocytosed yeast cells,
the yeast culture was enriched for strains mutated in genes
important for phagocytosis inhibition. The sites of insertion
were mapped for strains that individually demonstratedCell Hoincreased uptake by macrophages. Strikingly, this global
approach identified three independent insertional events each
into GAT201 and GAT204 (Figure S1C). We also identified the
copper transporter CTR2, a gene not regulated by Gat201 that
causes capsule defects when mutated and is thus presented
elsewhere (Chun and Madhani, 2010). We did not identify strains
with mutations in BLP1 in this screen, which is not surprising
given the mild phenotype of the blp1D single mutant. We also
did not identify capsule gene mutants; however, these strains
exhibit a growth defect (C.D.C. and H.D.M., unpublished data)
and are likely outcompeted during the selection process.
Another gene known to be involved in capsule-independent
phagocytosis, APP1, acts only in opsonized cells (Luberto
et al., 2003) and was not identified in our screen for unopsonized
phagocytosis. These data underline the importance of Gat201
and Gat204 in limiting phagocytosis of C. neoformans.
Gat204 andBlp1AreDispensable for Capsule Formation
Interestingly, the level of capsule, as detected by India ink
staining (Figure 2D), was unchanged in these mutants, unlike in
the gat201D strain (Liu et al., 2008). gat204D, blp1D, and
gat204Dblp1D mutants were also stained for b-glucan, chitin,
and mannoprotein but did not show any changes relative to
wild-type cells (data not shown), demonstrating that gross cell
surface architecture is unchanged in these mutants. Growth at
37C was unchanged in the gat204D and blp1D mutant strains
(Figure 3A). None of the mutants were deficient in the production
of melanin, a pigmented compound thought to be important for
virulence in the host (Figure 3B).
Blp1 Is Part of a Six-Gene Family in C. neoformans
SMART protein sequence analysis of Blp1 identified a conserved
Barwin-like domain (Figure S2C). This domain is found in
a number of protein families in plants, fungi, and bacteria, several























































































































































































































Figure 2. In Vitro Analysis of Gat204 and Blp1
(A) Activation of BLP1 and GAT204 by Gat201. BLP1 (left) and GAT204 (right) transcript levels were assessed in wild-type and gat201D cells grown in tissue
culture conditions for 24 hr. Error bars are standard deviation (SD) of two to four samples.
(B) Repression ofBLP1 byGat204.BLP1 transcript levels were assessed in wild-type and gat204D cells grown in tissue culture conditions for 24 hr. Error bars are
SD of two samples.
(C) Quantification of phagocytosis defects. RAW264.7 macrophages were coincubated with the designated C. neoformans strains for 24 hr then washed three
times with PBS to remove unphagocytosed yeast. Themacrophages were then counted to assay the number of macrophages with yeast associated. At least 200
macrophages were counted per well, and each strain was assayed in triplicate. By Student’s t test, the difference between blp1D and wild-type association with
macrophages was determined to be statistically significant.
(D) Quantitative measurements of capsule size. Capsule was induced in the indicated strains by incubation in tissue culture conditions for 24 hr. Capsule and cell
size were measured for at least 30 cells per strain, and the ratio of capsule to cell diameter calculated and averaged for each strain. Error bars represent the
standard deviation (SD).
See also Figure S1.
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a high probability (1.000) of a signal peptide. BLP1 appears to be
part of a six-member family in C. neoformans, all members of
which contain the Barwin-like domain and a signal sequence.248 Cell Host & Microbe 9, 243–251, March 17, 2011 ª2011 ElsevierInhibition of Phagocytosis Correlates with Effective
Colonization of the Lungs
To determine whether inhibition of phagocytosis by C. neofor-
mans correlates with its ability to colonize the lung, weInc.
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Figure 3. Antiphagocytosis Mutants Show Reduced Fitness during
Infection but Normal Rates In Vitro
(A) Growth rate measurements. Log-phase wild-type and mutant strains
were grown for 7 hours at 37C in YPAD medium, and OD600 was measured
every 2–3 hr. Error bars represent the SD for cultures grown in triplicate.
(B) Melanin assays. Melanin assay on L-DOPA plates demonstrates that none
of the strains are hypomelanized. gat201D is hypermelanized, as previously
noted in Liu et al. (2008). gat204D is also hypermelanized, as is the
gat204Dblp1D mutant.
(C) Mouse infection data. Approximately 1:1 mixtures of H99 and the indicated
mutant (marked with a nourseothricin [NAT] resistance gene) were inoculated
intranasally into mice (A/J) (53 105 total cells/mouse). The actual proportion of
mutant cells in each inoculum were determined by plating of a dilution of the
inoculum on nonselective medium and then assaying of 100–200 individual
colonies for NAT resistance. At 3 and 10 days after infection, animals were
sacrificed, and the lungs, brains, and spleen from each were homogenized
and serial dilutions were plated. One hundred to 200 colonies per organ
were assayed for NAT resistance to determine the percentage of mutant cells.
Error bars represent the SD from three mice per inoculum.
See also Figure S3.
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equal proportion with gat201D, gat204D, blp1D, or
gat204Dblp1D cells. As a control strain, we used a knockout
mutant in SXI1, which is not expressed in nonmating cells and
is dispensable for virulence (Hull et al., 2004). Inocula were
administered to mice through an inhalation model of infection.
The lungs were harvested after 3 or 10 days, and the proportion
of mutant to wild-type cells was assessed. Strikingly, weCell Hoobserved a correlation between the degree of phagocytosis inhi-
bition in a given strain and the relative ability of that strain to
colonize the lung tissue (Figure 3C). While the mutant cells
made up 50% of each inoculum, their prevalence after 3 or
10 days in the lungs correlated with their antiphagocytic abilities.
The gat201D strain, which showed the least phagocytic inhibi-
tion of all the strains tested, was entirely absent from lung tissue
homogenate-derived colonies. The gat204D strain, which
showed decreased phagocytic inhibition compared to the
wild-type, also displayed decreased representation in the lungs
(27% at 3 dpi, 19% at 10 dpi). gat204Dblp1D, which dis-
played a level of phagocytic inhibition between that of
gat201D and gat204D, showed a level of representation in the
lungs also intermediate to the two strains. The blp1D mutant,
which displayed the weakest phagocytosis phenotype, and
the control sxi1D mutant represented 50% of the cells recov-
ered from the lungs.DISCUSSION
Cryptococcus species produce a polysaccharide capsule, which
numerous studies have shown to be a major virulence factor and
an important mechanism of immune modulation. In particular,
capsule inhibits phagocytosis of C. neoformans by macro-
phages (Monari et al., 2006a). However, our previous work
demonstrates that the pleiotropic transcriptional activator
Gat201 controls a capsule-independent mechanism by which
C. neoformans evades phagocytosis but also regulates capsule
synthesis (Liu et al., 2008). Here, we describe a regulatory circuit
dissection approach to further illuminate capsule-independent
antiphagocytic mechanisms and to test their roles in infection.
The work described in this paper demonstrates that at least
two such mechanisms exist, begins to identify potential end
effectors of this regulatory circuit, and—importantly—provides
strong evidence that such mechanisms are important for
successful mammalian infection by C. neoformans.An Integrative Approach Identifies the Direct
Targets of the Gat201 Virulence Regulator
We found that over 1000 genes, or approximately one-sixth of
the C. neoformans genome, showed statistically significant
changes in expression in gat201D cells compared to the wild-
type. As expression ofGAT201 itself was induced in these condi-
tions, Gat201 could function downstream of a signaling
pathway(s) that senses environmental changes and modulates
a massive reprogramming of the cellular transcriptome.
To identify the direct targets of Gat201, we developed ChIP-
chip methods. Through this approach, we identified 126 genes
that demonstrate robust binding of Gat201 in their promoter
regions, 62 of which depend on Gat201 for transcript accumula-
tion in tissue culture conditions. Significantly, seven targets of
Gat201 themselves encode known or predicted transcription
factors, two of which, Liv3 and Cir1, have been previously impli-
cated in pathogenicity (Jung et al., 2006; Liu et al., 2008). The
results reported here implicate Gat204 in infectivity. Thus, it
appears that Gat201 is part of a critical large virulence transcrip-
tional regulatory network that controls pathogenicity in response
to environmental signals.st & Microbe 9, 243–251, March 17, 2011 ª2011 Elsevier Inc. 249
Cell Host & Microbe
Antiphagocytic Mechanisms in CryptococcosisSystematic Analysis Reveals the Existence of Multiple
Capsule-Independent Antiphagocytosis Mechanisms
Through a systematic gene disruption approach, we identified
two genes, BLP1 and GAT204, which affect the ability of
C. neoformans to evade unopsonized phagocytosis by macro-
phages. Together, these two genes recapitulate a significant
portion of the phenotype of the gat201D mutant strain. These
observations suggest that at least three mechanisms exist to
inhibit phagocytosis: GXM, those dependent on Blp1 and
Gat204, and at least one mechanism that is Gat201 dependent
but Blp1/Gat204 independent.Capsule-Independent Phagocytosis Inhibition and
Mammalian Infectivity of Cryptococcus neoformans
Finally, we have demonstrated that the relative ability of a given
strain to evade or inhibit phagocytosis correlates with its ability to
survive and proliferate within the lung tissue. We examined time
points relatively early in infection, when we expect alveolar
macrophages to play a crucial role in the initial host response,
but before a full adaptive immune response develops. Cells lack-
ing Gat201 are cleared from the lungs of infected mice within
3 days, demonstrating an early and pivotal role for this transcrip-
tion factor in pathogen success. Significantly, the analysis of
single and double mutants demonstrated that the roles of
Gat201, Gat204, and Blp1 in survival within the murine lung are
proportional to their impact on phagocytosis in vitro. The corre-
lation between the in vitro and in vivo data strongly indicates that
multiple capsule-independent antiphagocytosis mechanisms
are critical for infection of the mammalian host. Thus, while
a major focus of C. neoformans research has justifiably been
its polysaccharide capsule, this work demonstrates capsule-
independent antiphagocytic mechanisms are important for
successful host colonization.EXPERIMENTAL PROCEDURES
Gene Nomenclature
Genes were identified with annotation from the H99 sequence from the Broad
Institute (http://www.broadinstitute.org/annotation/genome/cryptococcus_
neoformans/MultiHome.html) and from our own annotation of the H99
sequence (http://cryptogenome.ucsf.edu/). Gene annotations from the Broad
Institute are designated by the nomenclature ‘‘CNAG_#,’’ while our own anno-
tations are designated ‘‘CDS_#.’’Strains and Media
C. neoformans growth conditions were as previously described (Chun et al.,
2007; Chun and Madhani, 2010; Liu et al., 2008), with minor modifications
found in the Supplemental Experimental Procedures.Phagocytois Assay
RAW264.7 macrophage assays were performed as previously described
(Chun andMadhani, 2010; Liu et al., 2008). Bonemarrow-derivedmacrophage
experiments were performed in much the same manner with minor modifica-
tions described in the Supplemental Experimental Procedures.Expression Profiling
Expression profiling was performed as previously described (Liu et al., 2008)
with minor modifications described in the Supplemental Experimental Proce-
dures. Analysis was performed as described in Chun et al. (2007).250 Cell Host & Microbe 9, 243–251, March 17, 2011 ª2011 ElsevierChIP-chip
The ChIP-chip tiling arrays were designed on 244,000 probes of 60 bp length,
averaging 80 bp between probes, across the entire H99 sequence as it was
published by theBroad Institute, current to 2007. Experiments were performed
as previously described (Nobile et al., 2009) withC. neoformans-specificmodi-
fications described in the Supplemental Experimental Procedures.
RT-qPCR
Gene expression differences observed using microarray-based transcript
profiling were confirmed utilizing RT-qPCR as previously described (Chun
et al., 2007) with minor modifications (see the Supplemental Experimental
Procedures).
A. tumefaciens-Mediated Transformation of C. neoformans
These experiments were performed as described in McClelland et al. (2005)
with minor modifications as described in Chun and Madhani (2010).
Phagocytosis Screen with Insertional Mutant Library
This procedure was performed as previously described (Chun and Madhani,
2010).
Capsule Assay
Experiments were performed as previously described (Liu et al., 2008). See the
Supplemental Experimental Procedures for more details.
Growth Curve
Overnight YPAD cultures grown at 37C were diluted back to OD600 = 0.1 in
YPAD, in triplicate. Cultures were grown at 37C for 7 hr, and the OD600 was
measured every 2–3 hr.
Melanin Assay
From overnight culture, C. neoformans cells were diluted to OD600 = 0.6 in
water then spotted onto melanin-inducing plates containing L-DOPA (L-dihy-
droxyphenylalanine, Sigma, 100 mg l-1) and grown for 3 days at 37C.
Intranasal Coinfection Experiments
Experiments were performed as described previously (Liu et al., 2008).
ACCESSION NUMBERS
Microarray data can be obtained from NCBI GEO at series accession
GSE27660.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at doi:10.1016/j.
chom.2011.02.003.
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